---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-020949"
form_type: "8-K"
ticker: "WINT"
cik: "0000946486"
company_name: "WINDTREE THERAPEUTICS INC /DE/"
filed_at: "2025-06-20T23:59:59+00:00"
generated_at: "2026-05-19T02:24:52.298833+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Windtree receives Nasdaq bid price deficiency letter; delisting risk if hearing not granted by June 25

## Summary
- Nasdaq notified Windtree on June 18, 2025 that closing bid price has been below $1.00 for 30 consecutive days.
- Company is ineligible for standard 180-day compliance period due to two reverse stock splits >250:1 over prior two years.
- Windtree must request a hearing by June 25, 2025, or face suspension/delisting from Nasdaq.
- Company intends to request a hearing; automatic stay of delisting pending hearing and any extension granted by Panel.
- Common stock continues trading under symbol WINT; no assurance of regaining compliance.

## SEC filing metadata
- accession: 0001437749-25-020949
- form_type: 8-K
- ticker: WINT
- cik: 0000946486
- company_name: WINDTREE THERAPEUTICS INC /DE/
- filed_at: 2025-06-20T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946486/000143774925020949/0001437749-25-020949-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946486/000143774925020949/wint20250620_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-020949
- JSON: https://secwatch.observer/filing/0001437749-25-020949.json
- Plain text: https://secwatch.observer/filing/0001437749-25-020949.txt

## Key facts
- Listing & Compliance Notices
  WINDTREE THERAPEUTICS INC /DE/ received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)(iv), 5815(4)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)(iv), 5815(4)(A)
  source text: June 18, 2025, Windtree Therapeutics, Inc. (the “ Company ”) received a deficiency letter (the “ Bid Price Deficiency Letter ”) from the Nasdaq Listing Qualifications Department (the “ Staff ”) notifying the Company that, for the last 30 consecutive business days, the closing bid price for the Company’s common stock, par value $0.001 per share (the “ Common Stock ”), has been below the minimum $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (“ Minimum Bid Price Requirement ”). Normally, a company would be afforded a 180-cal
  evidence_url: https://www.sec.gov/Archives/edgar/data/946486/000143774925020949/0001437749-25-020949-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.